NCT02723851View on ClinicalTrials.gov

Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects

UnknownOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
Myocardial Infarction
Interventions
DEVICE

Corsens

Recording and calculating Peak Endocardial Acceleration (PEA) Myocardial Contractility Index \[MCI\] and isovolumetric contraction (IVCT). Measurements will not affect the treatment provided to the patients.

Sponsors
All Listed Sponsors
lead

Corsens Medical LTD

INDUSTRY

NCT02723851 - Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects | Biotech Hunter | Biotech Hunter